[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Kyowa Kirin Co. Ltd.
Kyowa Kirin and Kura Oncology report combination data for KOMZIFTI with Venetoclax and Azacitidine in AML. Kura Oncology announces first commercial sale of KOMZIFTI, triggering a $XXX million payment from Kyowa Kirin.
About Kyowa Kirin Co. Ltd.
Kyowa Kirin Co. Ltd. is a pharmaceutical company.
Insights
- Kyowa Kirin Co. Ltd. creators is up XX% from the previous week.
- Kyowa Kirin Co. Ltd. engagements is up XXXXXX% from the previous week.
- Kyowa Kirin Co. Ltd. mentions is up XXX% from the previous week.
- Kyowa Kirin Co. Ltd. posts created is up XXX% from the previous week.
Price: $
Price 24-Hour Time-Series Raw Data
The price action is likely influenced by positive news regarding FDA approvals and new product launches, as indicated by social media discussions.
1-Year High: $XXXXX on 2025-08-07
1-Year Low: $XXXXXXXX on 2025-02-20
AltRank: XXXXX
AltRank 24-Hour Time-Series Raw Data
Kyowa Kirin Co. Ltd. is currently AltRank #1,029 based on combined combined social and market metrics
Daily Average: XXXXX
1-Year High: XXXXX on 2025-01-20
1-Year Low: XXX on 2025-11-26
Galaxy Score: XX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-11-13
1-Year Low: X on 2025-11-20
Engagements: XXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX +152%
X Month: XXXXXX -XX%
X Months: XXXXXXX +80%
X Year: XXXXXXX +37%
1-Year High: XXXXXX on 2025-09-09
1-Year Low: X on 2024-12-15
Engagements by network (24h): X: XXX
Mentions: X (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
X Week: XX +120%
X Month: XX +2.10%
X Months: XXX +37%
X Year: XXX +117%
1-Year High: XX on 2025-09-09
1-Year Low: X on 2024-12-13
Mentions by network (24h): X: XX
Creators: X (24h)
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning Kyowa Kirin Co. Ltd. in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: X
X Week: XX +80%
X Month: XX +2.80%
X Months: XXX +58%
X Year: XXX +51%
1-Year High: XX on 2025-09-09
1-Year Low: X on 2024-12-13
The most influential creators that mention Kyowa Kirin Co. Ltd. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Biopharma_Watch | X | XXXXX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Month: XXX% no change
X Months: XXX% no change
X Year: XXX% no change
1-Year High: XXX% on 2025-02-01
1-Year Low: X% on 2025-03-18
Most Supportive Themes:
- FDA Approvals and New Product Launches: (40%) Positive news regarding FDA approvals and new product launches is driving social media discussions.
- Market Growth and Expansion: (30%) Discussions indicate expected major growth in specific markets, such as Cutaneous T-cell Lymphoma.
- Partnerships and Collaborations: (30%) Mentions of collaborations with other pharmaceutical companies in treatment development.
Most Critical Themes:
- Financial Transactions and Payments: (60%) Significant financial transactions, including payments from Kyowa Kirin to other companies, are being highlighted.
- Drug Development and Approvals: (40%) Specific drugs like KOMZIFTI are being discussed in relation to FDA approval and commercial sales.
Market Cap: $undefined
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXXXX on 2024-12-13
1-Year Low: $XXXXXXXXXXXXXXXXX on 2025-02-19
Top Kyowa Kirin Co. Ltd. Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"One of the largest Pharma companies in Japan has a new CEO a foreigner following the much criticized Takeda model and the much failed Olympus model. May this time be different. Kyowa Kirin 4151"
X Link @Basteph_ 2025-12-12T05:22Z 5131 followers, XXX engagements
"Mucopolysaccharidosis Type I Market Dynamics Indicate Upward Trajectory Through 2034 Reports DelveInsight BioMarin Pharma Sanofi Orchard Therapeutics Kyowa Kirin JCR Pharma Nippon #Business #HealthMedicine #MarketingSales #PharmaceuticalsBiotech"
X Link @ABNewswire 2025-12-11T15:51Z 1656 followers, XX engagements
"$KURA 11.03$ -XXXX% 2025-12-08T15:30:00.000Z Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML"
X Link @Biopharma_Watch 2025-12-09T15:45Z 1229 followers, XXX engagements
"$NKTR $SNY $KYKOF (3) Programs w/ PEGylated IL-2 for selective IL-2R binding = expand #Tregs X. Nektar Rezpeg: Ph2b AtD Ph2 AA X. Sanofi SAR444336: Ph2 Microscopic Colitis X. Kyowa Kirin I129-W80"
X Link @HOThomasWPhelps 2025-12-05T05:32Z 1891 followers, 2353 engagements